QNRX

Quoin Pharmaceuticals, Ltd.

0.64 USD
+0.04 (+5.93%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Quoin Pharmaceuticals, Ltd. stock is up 5.41% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62.5% of the previous 8 July’s closed higher than June.

About Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals, Ltd. focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a topical lotion to treat Netherton Syndrome; QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease.